Lee Dongjoo, Danishefsky Samuel J
Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Tetrahedron Lett. 2009 May 13;50(19):2167-2170. doi: 10.1016/j.tetlet.2009.02.138.
A convergent synthesis of a unimolecular pentavalent-MUC1 glycopeptide has been accomplished. A tandem repeat of unglycosylated human tumor-associated MUC1, a potential target for cancer immunotherapy, was incorporated into the known unimolecular pentavalent carbohydrate construct (5). This is an important step towards the development of a new fully synthetic anti-cancer vaccine candidate (1).
已完成一种单分子五价-MUC1糖肽的汇聚合成。未糖基化的人肿瘤相关MUC1的串联重复序列(癌症免疫治疗的一个潜在靶点)被纳入已知的单分子五价碳水化合物构建体(5)中。这是朝着开发一种全新的全合成抗癌疫苗候选物迈出的重要一步(1)。